Bringing the fundamentals into focus…
Back to Collegium Pharmaceutical, Inc.
How Collegium Pharmaceutical, Inc. stacks up
COLL · against 557 other Healthcare companies listed in US-listed
Profitability
92/ 100
Near the top of its peers.
Ranked #45 of 558 · scores higher than 92% of peers
Bars: peers in each 10-point band of the profitability score61 peers with a profitability score of 90–100, including COLL · Click a bar to see the companies
Why profitability scores 92?
Weighted metrics compared with all Healthcare companies.Mainly thanks to its return on invested capital and operating margin, which are stronger than most Healthcare peers.
- Return on assets is close to the peer norm. Return on assets: 2.2% vs peer median 1.7%
- a wider operating margin: stronger than 80% of peers. Operating margin: 19.5% vs peer median 7.1%
- a higher return on invested capital: stronger than 97% of peers. Return on invested capital: 68.2% vs peer median 4.7%
Metric by metric
Position: dot = COLL, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | COLL | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Return on invested capitalHigher is better · 517 reported | 68.2% | -7.0% | 97% | 33% | |
| Operating marginHigher is better · 479 reported | 19.5% | -2.4% | 83% | 33% | |
| Return on assetsHigher is better · 582 reported | 2.2% | -7.8% | 69% | 33% | |
| Return on equityHigher is better · 531 reported | 17.6% | -19.7% | 85% | Context only | |
| Gross marginHigher is better · 601 reported | 89.4% | 43.9% | 90% | Context only |
Ranking by profitability score
Top 5 and the companies ranked around COLL| Rank | Company | Market cap | Profitability | Overall |
|---|---|---|---|---|
| 1 | 595M USD | 99 | 97 | |
| 1 | 433M USD | 99 | 81 | |
| 1 | 17.9B USD | 99 | 76 | |
| 1 | 52.9B USD | 99 | 57 | |
| 1 | 578M USD | 99 | 73 | |
| 40 | 1.5B USD | 93 | 93 | |
| 40 | 2.1B USD | 93 | 96 | |
| 40 | 40.2B USD | 93 | 73 | |
| 40 | 913M USD | 93 | 77 | |
| 45 | 773M USD | 92 | 64 | |
| 45 | 256M USD | 92 | 80 | |
| 45 | 1.8B USD | 92 | 80 | |
| 48 | 5.2B USD | 91 | 74 | |
| 48 | 449M USD | 91 | 72 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score